UniProt Q9A385
UPF0335 protein CC_3319 (Q9A385)
UPF0335 protein CC_3319 (UniProt Q9A385): 5 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q9A385
- Protein
- UPF0335 protein CC_3319
- Experimental structures
- 5
- Predicted models
- 1
- Ligands
- 1
Structures
6 records of Q9A385 in the MolNFT archive: 5 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6OZX | Wild type GapR crystal structure 1 from C. crescentus | x-ray diffraction | A | — | — |
| 6OZX | Wild type gapr crystal structure 1 from C. crescentus | x-ray diffraction | A | — | — |
| 6OZY | Wild type GapR crystal structure 2 from C. crescentus | x-ray diffraction | A, B | CD | — |
| 6OZY | Wild type gapr crystal structure 2 from C. crescentus | x-ray diffraction | A, B | CD | — |
| 6OZZ | N terminally deleted gapr crystal structure from C. crescentus | x-ray diffraction | A, B, C, D, E, F | — | — |
| Q9A385 | AlphaFold monomer V2.0 prediction for UPF0335 protein CC_3319 (Q9A385) | predicted | A | — | — |
Ligands
- CD · Cadmium ion · in 2 records
Experiment against prediction
- 6OZY chain B against the predicted model Q9A385: TM-score 0.97, RMSD 0.61 Å
- 6OZY chain B against the predicted model Q9A385: TM-score 0.97, RMSD 0.61 Å
- 6OZZ chain D against the predicted model Q9A385: TM-score 0.97, RMSD 0.59 Å
- 6OZZ chain B against the predicted model Q9A385: TM-score 0.94, RMSD 0.81 Å
- 6OZZ chain A against the predicted model Q9A385: TM-score 0.93, RMSD 0.89 Å
- 6OZX chain A against the predicted model Q9A385: TM-score 0.93, RMSD 1.03 Å
- 6OZX chain A against the predicted model Q9A385: TM-score 0.93, RMSD 1.03 Å
- 6OZY chain A against the predicted model Q9A385: TM-score 0.86, RMSD 1.45 Å
- 6OZY chain A against the predicted model Q9A385: TM-score 0.86, RMSD 1.45 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.